These weight loss medications, administered via injections, work by mimicking a hormone called GLP-1, which helps regulate appetite and blood sugar levels.

The AP-NORC poll results indicate that even as doctors urge the drugs’ use, some Americans continue to have concerns about weight-loss drugs, particularly for people who aren’t struggling with obesity ...

A front-of-package food label would be a great educational tool. The Trump administration should keep it.

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...

Weight loss jabs, such as Wegovy, have been linked to reduced risk of dementia and seizures – but increased risk of other ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.